multiple-myeloma

Documents about multiple-myeloma

• Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma#18540ClinicalTrials.gov
• Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma#18579ClinicalTrials.gov
• Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies#18599ClinicalTrials.gov
• Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma#28301ClinicalTrials.gov
• MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma#28326ClinicalTrials.gov
• Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant#332758ClinicalTrials.gov
• A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)#346908ClinicalTrials.gov
• Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma#349953ClinicalTrials.gov
• Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma#356473ClinicalTrials.gov
• Immunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma#366578ClinicalTrials.gov
• Evaluation of IGM-2644 in Adults With Relapsed and/or Refractory Multiple Myeloma#366600ClinicalTrials.gov
• A Feasibility and Safety Study of Dual Specificity CD38 and BCMA CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma#366611ClinicalTrials.gov
• Risk of adverse events in elotuzumab-treated patients with multiple myeloma: a systematic review and meta-analysis#4563Europe PMC
• Patient-Centered Education Through A Massive Open Online Course (MOOC) for Patients With Multiple Myeloma and Caregivers: Descriptive Study of Knowledge Gains by French Association of Patients With Multiple Myeloma (AF3M) and French-Speaking Myeloma Intergroup (IFM)#120678HAL (France)
• The location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of patients with high-risk NDMM#121829HAL (France)
• <b>Curriculum Vitae – Professor Salah Eddine Belakehal, MD | Senior Hematologist, Hospital Executive and Clinical Research Leader</b>#220412Figshare
• Optimal acquisition time of [⁶⁸Ga]Ga-PentixaFor PET/CT for initial staging of multiple myeloma: an ancillary study to the PentiMyelo protocol#288070HAL (France)

Related topics